NorthRock Partners »

Regeneron Pharmaceuticals shares owned by NorthRock Partners

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by NorthRock Partners from 13F filings

Historical chart of NorthRock Partners investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by NorthRock Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by NorthRock Partners

Quarter filed Position value Share count Share price at filing
2024-03-31 $253k 263 962.49
2023-12-31 $300k 341 878.29
2023-09-30 $205k 249 822.96
2023-03-31 $287k 349 821.67
2022-12-31 $264k 366 721.49
2021-09-30 $356k 589 604.41